Brigit Biofarmaka Teknologi Tbk. vs Sumber Mas Konstruksi Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Sumber Mas Konstruksi Tbk. trades at Rp70 (market cap 90.22B, 7.99M 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and Sumber Mas Konstruksi Tbk. is more actively traded (7.99M versus 592.2K). Which is the better fit depends on your goals.
| OBAT | SMKM | |
|---|---|---|
Market Cap | 172.82B | 90.22B |
Volume | 592.2K | 7.99M |
Lot | 5.92K | 79.89K |
Turnover | 147.05M | 552.39M |
Average Price | 248.31 | 69.15 |
Value | 147.05M | 552.39M |
Indicative Equilibrium Price | 254 | 70 |
Indicative Equilibrium Volume | 10 | 452 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Sumber Mas Konstruksi Tbk ("Company") formerly PT Rubenindo Artha Subur was established based on the Notarial Deed of E. Sianipar, S.H., No. 07 dated February 04, 1981.
Read more on SMKM →